The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Nasal Drug Delivery Systems Market Research Report 2024

Global Nasal Drug Delivery Systems Market Research Report 2024

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1426773

No of Pages : 92

Ask Your Query

Synopsis

 

Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. Intranasal Drug Delivery Devices are medical devices used for drug delivery through noses.

According to QYResearch’s new survey, global Nasal Drug Delivery Systems market is projected to reach US$ 55780 million in 2029, increasing from US$ 42310 million in 2022, with the CAGR of 3.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Nasal Drug Delivery Systems market research.

Key manufacturers engaged in the Nasal Drug Delivery Systems industry include Merck, GSK, AstraZeneca, Johnson & Johnson, BD, Pfizer, Baxter International, Bausch Health and Novartis, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Nasal Drug Delivery Systems were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Nasal Drug Delivery Systems market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Nasal Drug Delivery Systems market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  •     Merck
  •     GSK
  •     AstraZeneca
  •     Johnson & Johnson
  •     BD
  •     Pfizer
  •     Baxter International
  •     Bausch Health
  •     Novartis

Segment by Type

  •     Nasal Spray
  •     Nasal Powders
  •     Nasal Drops
  •     Nasal Gels
  •     Others

Segment by Application

  •     Hospitals Pharmacies
  •     Retail Pharmacies
  •     Online Pharmacies

Consumption by Region

  •  North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Nasal Drug Delivery Systems report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

 

 1.1 Product Overview and Scope of Nasal Drug Delivery Systems
    1.2 Nasal Drug Delivery Systems Segment by Type
        1.2.1 Global Nasal Drug Delivery Systems Market Value Comparison by Type (2023-2029)
        1.2.2 Nasal Spray
        1.2.3 Nasal Powders
        1.2.4 Nasal Drops
        1.2.5 Nasal Gels
        1.2.6 Others
    1.3 Nasal Drug Delivery Systems Segment by Application
        1.3.1 Global Nasal Drug Delivery Systems Market Value by Application: (2023-2029)
        1.3.2 Hospitals Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
    1.4 Global Nasal Drug Delivery Systems Market Size Estimates and Forecasts
        1.4.1 Global Nasal Drug Delivery Systems Revenue 2018-2029
        1.4.2 Global Nasal Drug Delivery Systems Sales 2018-2029
        1.4.3 Global Nasal Drug Delivery Systems Market Average Price (2018-2029)
    1.5 Assumptions and Limitations

 2 Nasal Drug Delivery Systems Market Competition by Manufacturers
    2.1 Global Nasal Drug Delivery Systems Sales Market Share by Manufacturers (2018-2023)
    2.2 Global Nasal Drug Delivery Systems Revenue Market Share by Manufacturers (2018-2023)
    2.3 Global Nasal Drug Delivery Systems Average Price by Manufacturers (2018-2023)
    2.4 Global Nasal Drug Delivery Systems Industry Ranking 2021 VS 2022 VS 2023
    2.5 Global Key Manufacturers of Nasal Drug Delivery Systems, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Nasal Drug Delivery Systems, Product Type & Application
    2.7 Nasal Drug Delivery Systems Market Competitive Situation and Trends
        2.7.1 Nasal Drug Delivery Systems Market Concentration Rate
        2.7.2 The Global Top 5 and Top 10 Largest Nasal Drug Delivery Systems Players Market Share by Revenue
        2.7.3 Global Nasal Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

 3 Nasal Drug Delivery Systems Retrospective Market Scenario by Region
    3.1 Global Nasal Drug Delivery Systems Market Size by Region: 2018 Versus 2022 Versus 2029
    3.2 Global Nasal Drug Delivery Systems Global Nasal Drug Delivery Systems Sales by Region: 2018-2029
        3.2.1 Global Nasal Drug Delivery Systems Sales by Region: 2018-2023
        3.2.2 Global Nasal Drug Delivery Systems Sales by Region: 2024-2029
    3.3 Global Nasal Drug Delivery Systems Global Nasal Drug Delivery Systems Revenue by Region: 2018-2029
        3.3.1 Global Nasal Drug Delivery Systems Revenue by Region: 2018-2023
        3.3.2 Global Nasal Drug Delivery Systems Revenue by Region: 2024-2029
    3.4 North America Nasal Drug Delivery Systems Market Facts & Figures by Country
        3.4.1 North America Nasal Drug Delivery Systems Market Size by Country: 2018 VS 2022 VS 2029
        3.4.2 North America Nasal Drug Delivery Systems Sales by Country (2018-2029)
        3.4.3 North America Nasal Drug Delivery Systems Revenue by Country (2018-2029)
        3.4.4 U.S.
        3.4.5 Canada
    3.5 Europe Nasal Drug Delivery Systems Market Facts & Figures by Country
        3.5.1 Europe Nasal Drug Delivery Systems Market Size by Country: 2018 VS 2022 VS 2029
        3.5.2 Europe Nasal Drug Delivery Systems Sales by Country (2018-2029)
        3.5.3 Europe Nasal Drug Delivery Systems Revenue by Country (2018-2029)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Nasal Drug Delivery Systems Market Facts & Figures by Country
        3.6.1 Asia Pacific Nasal Drug Delivery Systems Market Size by Country: 2018 VS 2022 VS 2029
        3.6.2 Asia Pacific Nasal Drug Delivery Systems Sales by Country (2018-2029)
        3.6.3 Asia Pacific Nasal Drug Delivery Systems Revenue by Country (2018-2029)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 Taiwan
        3.6.10 Indonesia
        3.6.11 Thailand
        3.6.12 Malaysia
        3.6.13 Philippines
    3.7 Latin America Nasal Drug Delivery Systems Market Facts & Figures by Country
        3.7.1 Latin America Nasal Drug Delivery Systems Market Size by Country: 2018 VS 2022 VS 2029
        3.7.2 Latin America Nasal Drug Delivery Systems Sales by Country (2018-2029)
        3.7.3 Latin America Nasal Drug Delivery Systems Revenue by Country (2018-2029)
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
    3.8 Middle East and Africa Nasal Drug Delivery Systems Market Facts & Figures by Country
        3.8.1 Middle East and Africa Nasal Drug Delivery Systems Market Size by Country: 2018 VS 2022 VS 2029
        3.8.2 Middle East and Africa Nasal Drug Delivery Systems Sales by Country (2018-2029)
        3.8.3 Middle East and Africa Nasal Drug Delivery Systems Revenue by Country (2018-2029)
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 U.A.E

 4 Segment by Type
    4.1 Global Nasal Drug Delivery Systems Sales by Type (2018-2029)
        4.1.1 Global Nasal Drug Delivery Systems Sales by Type (2018-2023)
        4.1.2 Global Nasal Drug Delivery Systems Sales by Type (2024-2029)
        4.1.3 Global Nasal Drug Delivery Systems Sales Market Share by Type (2018-2029)
    4.2 Global Nasal Drug Delivery Systems Revenue by Type (2018-2029)
        4.2.1 Global Nasal Drug Delivery Systems Revenue by Type (2018-2023)
        4.2.2 Global Nasal Drug Delivery Systems Revenue by Type (2024-2029)
        4.2.3 Global Nasal Drug Delivery Systems Revenue Market Share by Type (2018-2029)
    4.3 Global Nasal Drug Delivery Systems Price by Type (2018-2029)

 5 Segment by Application
    5.1 Global Nasal Drug Delivery Systems Sales by Application (2018-2029)
        5.1.1 Global Nasal Drug Delivery Systems Sales by Application (2018-2023)
        5.1.2 Global Nasal Drug Delivery Systems Sales by Application (2024-2029)
        5.1.3 Global Nasal Drug Delivery Systems Sales Market Share by Application (2018-2029)
    5.2 Global Nasal Drug Delivery Systems Revenue by Application (2018-2029)
        5.2.1 Global Nasal Drug Delivery Systems Revenue by Application (2018-2023)
        5.2.2 Global Nasal Drug Delivery Systems Revenue by Application (2024-2029)
        5.2.3 Global Nasal Drug Delivery Systems Revenue Market Share by Application (2018-2029)
    5.3 Global Nasal Drug Delivery Systems Price by Application (2018-2029)

 6 Key Companies Profiled
    6.1 Merck
        6.1.1 Merck Corporation Information
        6.1.2 Merck Description and Business Overview
        6.1.3 Merck Nasal Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
        6.1.4 Merck Nasal Drug Delivery Systems Product Portfolio
        6.1.5 Merck Recent Developments/Updates
    6.2 GSK
        6.2.1 GSK Corporation Information
        6.2.2 GSK Description and Business Overview
        6.2.3 GSK Nasal Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
        6.2.4 GSK Nasal Drug Delivery Systems Product Portfolio
        6.2.5 GSK Recent Developments/Updates
    6.3 AstraZeneca
        6.3.1 AstraZeneca Corporation Information
        6.3.2 AstraZeneca Description and Business Overview
        6.3.3 AstraZeneca Nasal Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
        6.3.4 AstraZeneca Nasal Drug Delivery Systems Product Portfolio
        6.3.5 AstraZeneca Recent Developments/Updates
    6.4 Johnson & Johnson
        6.4.1 Johnson & Johnson Corporation Information
        6.4.2 Johnson & Johnson Description and Business Overview
        6.4.3 Johnson & Johnson Nasal Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 Johnson & Johnson Nasal Drug Delivery Systems Product Portfolio
        6.4.5 Johnson & Johnson Recent Developments/Updates
    6.5 BD
        6.5.1 BD Corporation Information
        6.5.2 BD Description and Business Overview
        6.5.3 BD Nasal Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
        6.5.4 BD Nasal Drug Delivery Systems Product Portfolio
        6.5.5 BD Recent Developments/Updates
    6.6 Pfizer
        6.6.1 Pfizer Corporation Information
        6.6.2 Pfizer Description and Business Overview
        6.6.3 Pfizer Nasal Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
        6.6.4 Pfizer Nasal Drug Delivery Systems Product Portfolio
        6.6.5 Pfizer Recent Developments/Updates
    6.7 Baxter International
        6.6.1 Baxter International Corporation Information
        6.6.2 Baxter International Description and Business Overview
        6.6.3 Baxter International Nasal Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 Baxter International Nasal Drug Delivery Systems Product Portfolio
        6.7.5 Baxter International Recent Developments/Updates
    6.8 Bausch Health
        6.8.1 Bausch Health Corporation Information
        6.8.2 Bausch Health Description and Business Overview
        6.8.3 Bausch Health Nasal Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
        6.8.4 Bausch Health Nasal Drug Delivery Systems Product Portfolio
        6.8.5 Bausch Health Recent Developments/Updates
    6.9 Novartis
        6.9.1 Novartis Corporation Information
        6.9.2 Novartis Description and Business Overview
        6.9.3 Novartis Nasal Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
        6.9.4 Novartis Nasal Drug Delivery Systems Product Portfolio
        6.9.5 Novartis Recent Developments/Updates

 7 Industry Chain and Sales Channels Analysis
    7.1 Nasal Drug Delivery Systems Industry Chain Analysis
    7.2 Nasal Drug Delivery Systems Key Raw Materials
        7.2.1 Key Raw Materials
        7.2.2 Raw Materials Key Suppliers
    7.3 Nasal Drug Delivery Systems Production Mode & Process
    7.4 Nasal Drug Delivery Systems Sales and Marketing
        7.4.1 Nasal Drug Delivery Systems Sales Channels
        7.4.2 Nasal Drug Delivery Systems Distributors
    7.5 Nasal Drug Delivery Systems Customers

 8 Nasal Drug Delivery Systems Market Dynamics
    8.1 Nasal Drug Delivery Systems Industry Trends
    8.2 Nasal Drug Delivery Systems Market Drivers
    8.3 Nasal Drug Delivery Systems Market Challenges
    8.4 Nasal Drug Delivery Systems Market Restraints

 9 Research Finding and Conclusion

 10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List
    10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock